Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Leclerc

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Vaccine|May 31, 2008
Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformJérôme Denis, Elizabeth Acosta-Ramirez, Yinghi Zhao, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Virology|February 27, 2007
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerizationJérôme Denis, Nathalie Majeau, Elizabeth Acosta-Ramirez, et al.
Vaccines|July 24, 2020
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of AgeJoanne Langley, Elodie Pastural, Scott Halperin, et al.
Immunology|December 12, 2007
Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virusElizabeth Acosta-Ramírez, Rebeca Pérez-Flores, Nathalie Majeau, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 19, 2022
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infectionSanta-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Vaccine|May 31, 2008
Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platformJérôme Denis, Elizabeth Acosta-Ramirez, Yinghi Zhao, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 7, 2025
PapMV nanoparticles: A novel pathway to SARS-CoV-2 protection, distinct from ImidazoquinolinesMarilène Bolduc, Philippe Saint-Louis, Damien Carignan, et al.
Vaccines|April 27, 2026
Engineering a Modular PapMV Nanoparticle Vaccine: Comparative Efficacy of a Covalent and a Non-Covalent N-Antigen Vaccine Against Emerging SARS-CoV-2 VariantsLéa-J Blanchette, Marilène Bolduc, Tekeleselassie Woldemariam, et al.
Virology|February 27, 2007
Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerizationJérôme Denis, Nathalie Majeau, Elizabeth Acosta-Ramirez, et al.
Vaccines|July 24, 2020
A Randomized Controlled Study to Evaluate the Safety and Reactogenicity of a Novel rVLP-Based Plant Virus Nanoparticle Adjuvant Combined with Seasonal Trivalent Influenza Vaccine Following Single Immunization in Healthy Adults 18-50 Years of AgeJoanne Langley, Elodie Pastural, Scott Halperin, et al.
Immunology|December 12, 2007
Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virusElizabeth Acosta-Ramírez, Rebeca Pérez-Flores, Nathalie Majeau, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 19, 2022
A nanoparticle-based COVID-19 vaccine candidate elicits broad neutralizing antibodies and protects against SARS-CoV-2 infectionSanta-Mariela Olivera-Ugarte, Marilène Bolduc, Marie-Ève Laliberté-Gagné, et al.
Pageof 6